World's Best Scientists 2026 revealed!
Allan D. Sniderman

Allan D. Sniderman

D-Index & Metrics

Medicine

D-Index
94
Citations
32397
World Ranking
10489
National Ranking
422

Allan D. Sniderman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Allan D. Sniderman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 412 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Allan D. Sniderman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Allan D. Sniderman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2009 - Fellow of the Royal Society of Canada Academy of Science

Overview

Allan D. Sniderman is affiliated with McGill University in Canada and has contributed extensively to the field of Medicine, focusing mainly on Endocrinology, Diabetes and Metabolism. Their research also spans Surgery, Cancer Research, Cardiology and Cardiovascular Medicine, and Economics and Econometrics.

Key topics addressed in their body of work include:

  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Lipoproteins and Cardiovascular Health
  • Cancer, Lipids, and Metabolism
  • Health Systems, Economic Evaluations, Quality of Life
  • Lipid metabolism and disorders
  • Nutritional Studies and Diet
  • Acute Ischemic Stroke Management

Frequent co-authors in their publications include:

  • George Thanassoulis
  • Hongyan Ning
  • Norrina B. Allen
  • Venkatesh L. Murthy
  • Donald M. Lloyd-Jones

Their research has been published repeatedly in several notable venues, with multiple articles appearing in:

  • Journal of the American College of Cardiology
  • Circulation
  • JACC Advances
  • Journal of clinical lipidology
  • JAMA Cardiology

Recent publications by Allan D. Sniderman include:

  • Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related Risk, 2021, JAMA Cardiology
  • Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels, 2022, International Journal of Molecular Sciences
  • Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?, 2020, Current Cardiology Reports
  • The clinical utility of apoB versus LDL-C/non-HDL-C, 2020, Clinica Chimica Acta
  • Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE), 2022, Journal of Stroke

They were recognized as a Fellow of the Royal Society of Canada in 2009 within the Academy of Science.

Best Publications

  • Impact of left ventricular hypertrophy on survival in end-stage renal disease.

    Jonathan S. Silberberg;Paul E. Barre;Sarah S. Prichard;Allan D. Sniderman

  • Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

    Matthew J McQueen;Steven Hawken;Xingyu Wang;Stephanie Ounpuu

  • 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations

    Jacques Genest;Ruth McPherson;Jiri Frohlich;Todd Anderson

  • Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].

    Allan Sniderman;Stanley Shapiro;Derek Marpole;Bernard Skinner

  • The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.

    Lucien Campeau;Marc Enjalbert;Jacques Lespérance;Martial G. Bourassa

  • A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk

    Allan D. Sniderman;Ken Williams;John H. Contois;Howard M. Monroe

  • Application of New Cholesterol Guidelines to a Population-Based Sample

    Michael J. Pencina;Ann Marie Navar-Boggan;Ralph B. D'Agostino;Ken Williams

  • Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

    AD Sniderman;CD Furberg;A Keech;JE Roeters van Lennep

  • Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects

    May Faraj;Peter J. Havel;Steve Phélis;David Blank

  • Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

    P J Barter;C M Ballantyne;R Carmena;M Castro Cabezas

  • Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus

    Allan D. Sniderman;Thea Scantlebury;Katherine Cianflone

  • Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis

    Allan D Sniderman;Raj Bhopal;Dorairaj Prabhakaran;Nizal Sarrafzadegan

  • Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease

    Ann Marie Navar-Boggan;Eric D. Peterson;Ralph B. D’Agostino;Benjamin Neely

  • Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.

    Michael H. Davidson;Christie M. Ballantyne;Terry A. Jacobson;Vera A. Bittner

  • The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.

    Göran Walldius;Ingmar Jungner;Are H Aastveit;Ingar Holme

  • Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis.

    Allan D. Sniderman;Christina Wolfson;Babie Teng;Frank A. Franklin

  • Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.

    K M Cianflone;Z Yasruel;M A Rodriguez;D Vas

  • Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.

    Babie Teng;A. D. Sniderman;A. K. Soutar;G. R. Thompson

  • Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review.

    Allan D. Sniderman;George Thanassoulis;Tamara Glavinovic;Ann Marie Navar;Ann Marie Navar

  • Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

    A. Sniderman;C.D. Furberg;A. Keech;J.E. Roeters van Lennep

Frequent Co-Authors

Katherine Cianflone
Katherine Cianflone Université Laval
Michael J. Pencina
Michael J. Pencina Duke University
Kenneth R. Williams
Kenneth R. Williams Yale University
Ralph B. D'Agostino
Ralph B. D'Agostino Wake Forest University
Curt D. Furberg
Curt D. Furberg Wake Forest University
Donald M. Lloyd-Jones
Donald M. Lloyd-Jones Northwestern University
Seth S. Martin
Seth S. Martin Johns Hopkins University
Keith N. Frayn
Keith N. Frayn University of Oxford
Michael V. Holmes
Michael V. Holmes University of Oxford
Matthew J. McQueen
Matthew J. McQueen McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always mean you need to pursue the traditional MD route in the USA. There are a variety of flexible, valuable online degree programs that can lead to rewarding healthcare careers. For example, those interested in mental health can explore online msn pmhnp programs, which train you to become a Psychiatric Mental Health Nurse Practitioner.

If you have an interest in healthcare leadership, options like the online master of health administration provide pathways into management roles. These programs emphasize skills in policy, operations, and leadership across medical institutions.

Cost is often a concern for students, but there are online mha programs affordable, helping you advance your career without a large financial burden. For those already holding a BSN, specialized programs like the best online bsn to dnp programs can help you reach top clinical and leadership positions.

These diverse online degrees offer flexible, accessible alternatives to traditional medical study and open a range of dynamic healthcare career pathways.

Best Scientists Citing Allan D. Sniderman

Trending Scientists

Recently Published Articles